Key Record Dates
ClinicalTrials.gov Identifier: | NCT02508467 |
---|---|
Brief Title: | A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma |
First Submitted : | July 9, 2015 |
First Submitted that Met QC Criteria : | July 23, 2015 |
First Posted : | July 27, 2015 (Estimate) |
Last Update Submitted that Met QC Criteria : | August 12, 2022 |
Last Update Posted : | August 15, 2022 |